综述:妊娠期与哺乳期烧心的管理
该综述基于PubMed和MEDLINE 1966至2019年的英文文献,总结妊娠期和哺乳期烧心的病理、诊断与治疗。妊娠期反流影响高达80%孕妇,多数症状在哺乳期缓解。治疗采用阶梯式策略:首先生活方式调整,一线药物为抗酸剂、藻酸盐和硫糖铝,症状持续可用H2受体拮抗剂(除尼扎替丁),难治或复杂性GERD用PPI。
要点
- 妊娠期反流常见,影响高达80%孕妇,多数哺乳期缓解。
- 一线药物为抗酸剂、藻酸盐和硫糖铝,失败可用H2RA(除尼扎替丁)。
- PPI用于难治性或复杂性GERD,除奥美拉唑为C类外均为FDA B类。
核心结论
- 妊娠期和哺乳期烧心管理始于生活方式调整,疾病加重时医生需与患者详细讨论药物风险与获益。
研究设计与样本
- 综述,检索PubMed和MEDLINE 1966至2019年英文文献,筛选摘要并追溯参考文献。
主要发现
- 妊娠期反流影响高达80%孕妇,多数症状在哺乳期缓解。
- 仅小部分相关药物在妊娠或哺乳期禁用,但并非所有药物均经过充分评估。
- 抗酸剂、藻酸盐和硫糖铝为一线治疗;症状持续可用H2RA,但尼扎替丁因动物致畸或危害除外。
- PPI用于难治性症状或复杂性GERD,除奥美拉唑为FDA C类外均为B类。
关键数值与推荐
- 妊娠期反流影响高达80%孕妇。
- 尼扎替丁因胎儿致畸性或动物研究危害不推荐。
- PPI中奥美拉唑为FDA C类,其余为B类。
临床怎么用
- 妊娠期和哺乳期烧心先进行生活方式调整,无效时阶梯式加用抗酸剂、藻酸盐或硫糖铝。
- 症状持续可选用H2RA,但避免尼扎替丁。
- 难治性或复杂性GERD可选用PPI,优先选择FDA B类PPI(奥美拉唑为C类)。
- 用药前需与患者详细讨论风险与获益。
局限性
- 并非所有药物在孕妇或哺乳期得到充分评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gestational reflux is common, affecting up to 80% of pregnant women. Most symptoms will abate during lactation. During both of these periods, interventions used to relieve symptoms focus on a "step-up" methodology with progressive intensification of treatment. This begins with lifestyle modifications. AIM: To provide guidance in the treatment of reflux in pregnancy and lactation, as well as briefly summarising the pathogenesis, clinical presentation and diagnostic workup. METHODS: A comprehensive search, using online databases PubMed and MEDLINE, along with relevant manuscripts published in English between 1966 and 2019 was used. All abstracts were screened, potentially relevant articles were researched, and bibliographies were reviewed. RESULTS: Only a small percentage of relevant drugs are contraindicated for use in pregnancy or while breastfeeding. However, not all drug agents have been extensively evaluated in pregnant women or during the breastfeeding period. Antacids, alginates, and sucralfate are the first-line therapeutic agents. If symptoms persist, any of the H2 RAs can be used except for nizatidine (due to foetal teratogenicity or harm in animal studies). PPIs are reserved for women with intractable symptoms or complicated GERD; all are FDA category B drugs, except for omeprazole, which is a category C drug. CONCLUSIONS: The management of heartburn during pregnancy and lactation begins with lifestyle modifications. In situations where disease severity increases, medical providers must discuss risks and benefits of these medicines with the patient in detail.
引用
- Thélin CS, Richter JE. Review article: the management of heartburn during pregnancy and lactation. Aliment Pharmacol Ther. 2020. PMID: 31950535. doi:10.1111/apt.15611
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。